Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-27

Clinical Trial Update: WePrEP: Developing a PrEP Shared Decision-making Tool for Transgender Women [NA]

View source ↗

Summary

A study to develop and evaluate WePrEP, a shared decision-making tool for HIV prevention among transgender women; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Colorado, Denver | Conditions: HIV Prevention | NA | Status: RECRUITING